Denali Therapeutics Inc. - DNLI

About Gravity Analytica
Recent News
- 09.09.2025 - September 9, 2025 8:25 AM PDT - September 9, 2025 8:55 AM PDT : Baird 2025 Global Healthcare Conference
- 09.09.2025 - September 9, 2025 8:25 AM PDT - September 9, 2025 8:55 AM PDT : Baird 2025 Global Healthcare Conference
- 09.08.2025 - September 8, 2025 10:05 AM PDT - September 8, 2025 10:40 AM PDT : Morgan Stanley 23rd Annual Global Healthcare Conference
- 09.08.2025 - September 8, 2025 10:05 AM PDT - September 8, 2025 10:40 AM PDT : Morgan Stanley 23rd Annual Global Healthcare Conference
- 09.03.2025 - September 3, 2025 11:45 AM PDT - September 3, 2025 12:15 PM PDT : Cantor Global Healthcare Conference 2025
- 09.03.2025 - September 3, 2025 11:45 AM PDT - September 3, 2025 12:15 PM PDT : Cantor Global Healthcare Conference 2025
- 08.11.2025 - Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
- 08.11.2025 - Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
- 08.11.2025 - Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
- 08.07.2025 - Transferrin receptor–targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA
Recent Filings
- 08.14.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.14.2025 - 4 Statement of changes in beneficial ownership of securities
- 08.13.2025 - 144 Report of proposed sale of securities
- 08.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 08.12.2025 - 144 Report of proposed sale of securities
- 08.12.2025 - 144 Report of proposed sale of securities
- 08.11.2025 - 8-K Current report
- 08.11.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 08.11.2025 - EX-99.1 EX-99.1
- 08.07.2025 - 4 Statement of changes in beneficial ownership of securities